Page 1 of Clinical Trials for Drug BL-1020, 5 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia
Last Updated: May 21, 2012
Condition(s): Schizophrenia; Cognitive Effect on Schizophrenic Patients
2
Completed
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
Last Updated: June 27, 2010
Condition(s): Schizophrenia
3
Completed
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
Last Updated: June 27, 2010
Condition(s): Schizophrenia
4
Completed
A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
Last Updated: July 20, 2009
Condition(s): Healthy
5
Completed
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
Last Updated: July 20, 2009
Condition(s): Schizophrenia; Schizoaffective Disorder

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+BL-1020

Page 1 of Clinical Trials for Drug BL-1020, 5 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About